FDA
- Status: approved
adjustment of the dosages of immunosuppressants (adjustment of the dosages of immunosuppressants) regulatory status in United States.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA has authorised it.
CAMC Health System is the originator. The local marketing authorisation holder may differ — check the official source linked above.